News
The efficacy of antioxidant treatment with mexidol forte in 250 patients with chronic cerebral venous insufficiency
11.06.2021
Objective. To study the efficacy and safety of complex treatment with 2-ethyl-3-hydroxy-6-methylpyridine (mexidol forte 250) and venotonic drugs L-lysine aescinat and diosmin/hesperidin in patients with chronic cerebral venous insufficiency (CCVI).
Possibilities of improving the effectiveness of therapy in patients with chronic cerebral ischemia against the background of COVID-19
03.06.2021
Objective. To study the possibility of improving the efficacy of treatment with mexidol in COVID‑19 patients with chronic cerebral ischemia (CCI).